Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Fmr LLC

Fmr LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,971,085 shares of the medical equipment provider’s stock after buying an additional 838,793 shares during the quarter. Fmr LLC owned 3.08% of Intuitive Surgical worth $5,389,765,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in ISRG. Creekmur Asset Management LLC raised its stake in shares of Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new stake in Intuitive Surgical in the 2nd quarter valued at about $26,000. Godsey & Gibb Inc. boosted its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the period. LRI Investments LLC acquired a new position in shares of Intuitive Surgical during the first quarter worth about $30,000. Finally, LGT Financial Advisors LLC increased its stake in shares of Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other news, insider Jamie Samath sold 22,903 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. This trade represents a 72.34 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total value of $90,655.48. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,655,048.26. The trade was a 3.30 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 50,539 shares of company stock worth $26,112,364. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Down 2.1 %

Shares of ISRG stock opened at $536.55 on Tuesday. The stock’s 50-day moving average price is $505.63 and its 200 day moving average price is $465.19. The stock has a market capitalization of $191.11 billion, a PE ratio of 86.26, a price-to-earnings-growth ratio of 5.39 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $304.50 and a 52-week high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently issued reports on ISRG. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Leerink Partners increased their price objective on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and raised their target price for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Raymond James upped their price target on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $524.61.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.